Skip to main content
CABR
NASDAQ Industrial Applications And Services

Nasdaq Denies Continued Listing; Delisting Looms for Caring Brands

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.3
Mkt Cap
$11.819M
52W Low
$0.056
52W High
$6
52W Position
Off High info
78% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

CABR filed a Legal and Risk Events on light trading volume (0.3× avg).

Summary

Nasdaq denied Caring Brands' continued listing, setting a July 24 suspension date. The company will appeal, but the denial underscores its precarious financial position.


Key Events · Legal and Risk Events · CABR

  • Nasdaq Denies Continued Listing

    On July 15, 2026, Nasdaq Staff issued a Delisting Determination denying the company's request for continued listing on the Nasdaq Capital Market, citing failure to meet the $2.5M stockholders' equity requirement and lack of a definitive compliance plan.

  • Trading Suspension Set for July 24

    Unless the company requests a hearing by July 22, 2026, trading will be suspended at the open on July 24, 2026, and Nasdaq will file a Form 25-NSE to delist the stock.

  • Company to Appeal, Staying Suspension

    Caring Brands intends to request a hearing by July 21, 2026, which will stay the suspension and allow the stock to continue trading during the appeal process, though no assurance of success is given.

  • Compliance Plan Deemed Insufficient

    Nasdaq rejected the company's plan to amend its Series A Preferred Stock terms and obtain additional PIPE financing, stating no definitive agreements were in place to ensure near-term and sustained compliance.


Analysis · CABR · Industrial Applications And Services

Nasdaq has formally denied Caring Brands' request to remain listed, citing insufficient progress on its compliance plan. The company's equity fell below the $2.5M minimum, and the Staff determined the proposed fixes—amending preferred stock terms and securing additional PIPE financing—lacked definitive agreements. Trading will be suspended July 24 unless a hearing is requested by July 22. While the company intends to appeal, the denial signals deep skepticism about its near-term viability. This follows a string of distress signals: a going-concern warning, negative equity, and a recent $400K PIPE at deeply discounted terms. Delisting would severely impair liquidity and likely trigger forced selling, compounding the company's fragile state.

At the time of this filing, CABR was trading at $1.30 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $11.8M. The 52-week trading range was $0.06 to $6.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CABR - Latest Insights

CABR
Jul 17, 2026, 5:03 PM EDT
Source: Wiseek News
Importance Score:
9
CABR
Jul 17, 2026, 5:00 PM EDT
Filing Type: 8-K
Importance Score:
9
CABR
Jul 16, 2026, 5:12 PM EDT
Filing Type: 8-K
Importance Score:
8
CABR
Jul 14, 2026, 5:27 PM EDT
Filing Type: 8-K
Importance Score:
8
CABR
Jun 01, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
8
CABR
Jun 01, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
CABR
May 15, 2026, 4:30 PM EDT
Filing Type: PRE 14A
Importance Score:
9
CABR
May 12, 2026, 4:30 PM EDT
Filing Type: 10-Q
Importance Score:
9
CABR
May 05, 2026, 6:37 PM EDT
Filing Type: S-1
Importance Score:
9
CABR
Apr 10, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
9